The chromogranin a-derived vasostatins: new players in the endocrine heart.

The chromogranin a-derived vasostatins: new players in the endocrine heart. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The chromogranin a-derived vasostatins: new players in the endocrine heart. Abstract Text:

Over the last 50 years, increasing evidence has documented the ability of cardiac non-neuronal cells to synthesize and release catecholamines (CAs) and the vasorelaxant natriuretic peptides (NPs), which both regulate cardiovascular homeostasis in health and disease. This knowledge has firmly established the concept of the heart as an endocrine organ. The contents of this frame have been richly expanded by the identification of an increasing number of intracardiac endocrine modulators, including Chromogranin-A (CgA) and its derived peptides. In the rat heart, CgA is co-stored and co-released with Atrial NP (ANP) in non-adrenergic myoendocrine atrial cells as well as in atrial and ventricular Purkinje fibres. In the ventricular myocardium of the human hypertrophic and dilated heart, CgA co-localizes with B-type NP (BNP). CgA is the precursor of biologically active peptides produced by proteolytic cleavage. One of them, the human recombinant 1-76 CgA-derived vasostatin-1 (VS-1), is an inhibitor of cardiac contraction and relaxation, a non-competitive counter-regulator of beta-adrenergic stimulation and a protecting agent in ischemic preconditioning. Therefore, it may function as a cardiocirculatory homeostatic stabilizer, particularly in the presence of intense adrenergic stimuli, e. g. under stress responses. Since in patients with chronic heart failure circulating CgA levels increase up to 10-20 nM, depending on the severity of the disease and are independent prognostic indicators of mortality, knowledge on the physio-pathological significance of locally produced and/or circulating CgA-derived peptides, as attemped in this synopsis, may pave the way for clinically-oriented cardiovascular applications.

The chromogranin a-derived vasostatins: new players in the endocrine heart. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The chromogranin a-derived vasostatins: new players in the endocrine heart. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current medicinal chemistry

VOLUME: 15

Page Numbers: 1444-51

Journal Abbreviation: Curr. Med. Chem.

ISSN: 0929-8673

DAY: 9

MONTH: 06

YEAR: 2008

The chromogranin a-derived vasostatins: new players in the endocrine heart. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9440157

The chromogranin a-derived vasostatins: new players in the endocrine heart. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The chromogranin a-derived vasostatins: new players in the endocrine heart. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The chromogranin a-derived vasostatins: new players in the endocrine heart.

AFFILIATION: Department of Pharmaco-Biology, and Department of Cell Biology, University of Calabria, 87030 Arcavacata di Rende (CS), Italy. tota@unical.it.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Med Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The chromogranin a-derived vasostatins: new players in the endocrine heart Related Publications

• Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
• Differential NOS expression in freshwater and aestivating Protopterus dolloi (lungfish): Heart vs kidney readjustments.
• Growth hormone enables effective nutrition by peripheral vein in postoperative patients: a pilot study.
• Nitric oxide, a survival factor for lens epithelial cells.
• Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels.
• Role of nutrition in the management of malnutrition and immune dysfunction of trauma.
• The chromogranin a-derived vasostatins: new players in the endocrine heart.
• [TRANSACETYLATION REACTIONS IN SOME NEOPLASTIC TISSUE.]